Zantac 150 and Chest pain aggravated - a phase IV clinical study of FDA data

Summary:

Chest pain aggravated is reported as a side effect among people who take Zantac 150 (ranitidine hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Plavix, and have High blood pressure.

The phase IV clinical study analyzes which people have Chest pain aggravated when taking Zantac 150. It is created by eHealthMe based on reports of 5,708 people who have side effects when taking Zantac 150 from the FDA, and is updated regularly.

What is Zantac 150?

Zantac 150 has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 6,519 Zantac 150 users. Check the latest studies of Zantac 150.

What is Chest pain aggravated?

Chest pain aggravated is found to be associated with 2,207 drugs and 873 conditions by eHealthMe. Check the latest studies of Chest pain aggravated.

On Jul, 18, 2026

5,708 people reported to have side effects when taking Zantac 150.
Among them, 103 people (1.8%) have Chest pain aggravated.

Could Zantac 150 cause Chest pain aggravated?

Among these 103 people:

How long have people been on Zantac 150 when they have Chest pain aggravated? *

Click here to view more results

What is the gender of people who have Chest pain aggravated when taking Zantac 150? *

Click here to view

What is the age of people who have Chest pain aggravated when taking Zantac 150? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Zantac 150 and have Chest pain aggravated?

- Check whether Chest pain aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zantac 150:

Zantac 150 (6,519 reports)

Chest pain aggravated treatments and more:

Chest pain aggravated (94 reports)

How severe was Chest pain aggravated and when was it recovered:

Chest pain aggravated in Zantac 150

Expand to all the drugs that have ingredients of ranitidine hydrochloride:

Chest pain aggravated and drugs with ingredients of ranitidine hydrochloride (3,874 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zantac 150:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Chest pain aggravated:

Chest pain aggravated (2,207 drugs)

Browse all the conditions that are associated with Chest pain aggravated:

Chest pain aggravated (873 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ranitidine hydrochloride (the active ingredients of Zantac 150) and Zantac 150 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.